Evogene Q2 Revenue Grows 131% YoY, Here Is What You Need To Know
Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN) Q2 2022 revenue was $312,000, an increase of 131% compared to $135,000 in the same period the previous year.
Evogene Q2 EPS $(0.21) Misses $(0.17) Estimate, Sales $312.00K Beat $270.00K Estimate
Evogene (NASDAQ:EVGN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.17) by 23.53 percent. This is a 40 percent decrease over losses of $(0.15) per share from the same
Earnings Scheduled For August 31, 2022
Companies Reporting Before The Bell
• Hywin Holdings (NASDAQ:HYW) is expected to report earnings for its fourth quarter.
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
Gainers
Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.
ICL And Lavie Bio Enter Collaboration To Develop Novel Bio-Stimulant Products; ICL To Invest $10M In Lavie Bio
ICL to invest $10 million in Lavie Bio
ICL (NYSE:ICL) (TASE: ICL), a leading global specialty minerals company, and Evogene Ltd. (NASDAQ:EVGN) (TASE: EVGN), a leading computational biology company focused
This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
Earnings Scheduled For May 26, 2022
Companies Reporting Before The Bell
• American Woodmark (NASDAQ:AMWD) is likely to report quarterly earnings at $1.34 per share on revenue of $493.20 million.
Evogene’s Earnings: A Preview
Evogene (NASDAQ:EVGN) is set to give its latest quarterly earnings report on Thursday, 2022-05-26. Here's what investors need to know before the announcement.
Analysts estimate that Evogene will report an earnings per share (EPS) of $-0.17.
Evogene Shares Quiet Following Circulation Of US Patent & Trademark Office Doc For Co.’s ‘ISOLATED POLYPEPTIDES AND POLYNUCLEOTIDES USEFUL FOR INCREASING NITROGEN USE EFFICIENCY, ABIOTIC STRESS TOLERANCE, YIELD AND BIOMASS IN PLANTS’
https://patentcenter.uspto.gov/#!/applications/17026368/ifw/docs